Table 3
Probability of long-term outcomes and responses according to 3-month BCR-ABL levels across several clinical trials [31,41,42,44,45,46,47]
![Probability of long-term outcomes and responses according to 3-month BCR-ABL levels across several clinical trials [31,41,42,44,45,46,47]](https://karger.silverchair-cdn.com/karger/content_public/journal/aha/130/4/10.1159_000353163/2/m_000353163_t03.jpeg?Expires=1716311070&Signature=2-8CLQrjQ3bLJXRuW9ecoXMmuLFwZA6VPqeot8L24bukXyEO6eSsWhGWNWd2RfU8WY~huKEiNCCxqVJJCAUtGSKOffi4Wmb8AyqlKyvsjz4U4UU27oZYrkSKZ~9VNAOfOEyYg1Yt7KbzRaTkTrX1Jup1Nvp1GtA9TEUx7f~Ra~qdsX33Uqtrwn3RoZgAjrx9F52OyAa6nJhYrHb70UgBMs5RXw0Prhzs56yMv4ykDZwc~PM4JlRaezXIU2TZBNDIXTXAnbprVp7pGKRsnxrhpqGRuubeNMFkB6bwXzE4~qqsUpZ4UahqGcj08jzIBhb57txci9NwXfpsohxX6TdFgQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Probability of long-term outcomes and responses according to 3-month BCR-ABL levels across several clinical trials [31,41,42,44,45,46,47]